The Role of Human Milk in Development of Breast Fed Child's Intestinal Microbiota
NCT ID: NCT01548313
Last Updated: 2019-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
294 participants
OBSERVATIONAL
2010-05-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
NUTRIPROTECT-Children Nutrition as a Protective or Health-risk Factor
NCT04076592
The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term Infants
NCT05992493
Oral Supplement for Pregnant and Lactating Mothers
NCT01073033
Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants
NCT03477669
Evaluation of Safety, Growth, Tolerance and Effects on the Intestinal Fora of a New Milk for Healthy Infants
NCT00920166
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Mothers and their respective infants will be recruited in the maternity hospitals in three Slovenian regions: Ljubljana, Murska Sobota and Izola. Pregnant women will be invited to participate in the study by informative leaflets during their first visits in the health care centres or gynaecological clinics. All pregnant women who will express interest to participate and fulfilling the participation criteria will be invited to the introductory meeting where they will be informed about the study and will get during 1-hour course, instructions about the writing of 4-day weighed dietary protocol. The meetings will be carried out in the selected regional maternity hospitals. All volunteers willing to participate in the study will get the possibility to get our opinion about their diet during the pregnancy as well as later, during lactation period. The volunteers pregnant women will be also asked to precisely register every probiotic food product or food supplement which they will eat during the last three months of pregnancy and during 4 weeks after delivery.
Informed consent:
The study will be described to pregnant women by principal investigator and/or co-investigators. Following the explanation, the interested pregnant women will be given a written description of the study and the approved informed consent to sign. One copy of the signed document will be provided to the mother and one copy will be retained in the records of the clinical study.
The mothers and respective infants fulfilling the participation criteria for further research will receive written instructions and especially designed health care diary for follow up child's first year health and performance.
The mother will give the second or the third day after the delivery, under the supervision of medical staff, the sample of colostrum. If available, the sample of infant´ meconium will be taken at the same time. Both samples will be subjected to the analyses of microbiota. Samples of mature human milk will be taken under the supervision of medical staff at the first visit of the paediatrician, i.e. 4 weeks after delivery (for determination of fatty acids and microbiota), and again between 12th and 14th week after delivery. Mothers will be asked to bring with also a sample of child's faeces. Cooperation between researchers and respective paediatricians in the health care centres responsible for the infants involved in the study will be also established in order to get insight in the basic data about the development and health of infants.
All infants will be followed up from birth to the age of 12 months according to: a) growth, b) feeding regime, c) development d) bone mineral density and e) health. During their first 12 months of life examinations will take part on six occasions:
* Immediately after birth and during the first three days of life
* At first month (age 28 to 38 days)
* At third month (age 80 to 100 days)
* At sixth month (age 110 to 130 days)
* At ninth month (age 260 to 280 days)
* At twelfth month of age (age 355 to 375 days).
For following growth, development and health standard paediatrics' protocols will be used. Feeding regime will be annotated as:
* exclusively breast feed (BF)
* partially BF (BF + formula)
* only formula. Data will be gathered from maternity department medical charts, from regular paediatric health care visits at the dispensaries and from especially designed health care diary each mother will keep until the end of her child's first year.
The researchers will be responsible for the collecting and keeping records of data about all volunteers involved, of their diaries and of data obtained from paediatricians from health care centres.
Long-chain polyunsaturated fatty acids (LCP), especially docosahexaenoic acid (DHA, C22:6n-3) play an important role for the optimal development and maturation of the nervous system. Adequate supply of LCP, especially of DHA, plays an important role during the period of accelerated growth and differentiation of fetal nervous system during the last trimester of pregnancy and in the first year of life. Recently new Consensus recommendations on dietary fat intake in pregnancy and lactation were issued. We aim to investigate whether dietary intake of Slovenian pregnant and lactating women is in accordance with those new recommendations as well as if their dietary intake is healthy.
Special attention will be given to consumption of LCP and probiotic fermented dairy products. The consumption of probiotic food supplements will be registered as well.
Pregnant women (n=300) from three regions of Slovenia, i.e. Ljubljana with surrounding area (n=100), Izola with surrounding area (n=100) and Murska Sobota with surrounding area (n=100), will be included in the study.
Diet will be examined by the use of 4-day weighed dietary protocol (4DP) which will be done twice:
1. during the pregnancy: in the last third of pregnancy (between 27th and 28th week of pregnancy)
2. during the breast-feeding: 4 weeks after delivery
Objectives:
* to investigate weather nutrition of pregnant and lactating Slovenian women is in accordance with the Central European dietary guidelines
* to investigate whether nutrition of pregnant and lactating Slovenian is in accordance with the recent consensus recommendations on dietary fat intake during pregnancy and lactation
* to evaluate the frequencies of consumption of probiotic products (data will be important for screening the breast milk for the presence of commercially important probiotics)
During the study mothers will continue with their ordinary diet. For all participating women, a lecture and one-hour course with practical examples and demonstrations by the use of a balance and examples of foods, about how to write a 4-day weighed dietary protocol (4DP) will be organised. After the evaluation of diaries, the mothers will also have a possibility to ask for an expert opinion about their diet during the pregnancy as well as during lactation.
At the University Medical Centre of Ljubljana, Division of Paediatrics, the collected data will be evaluated by the help of computer program Prodi 5.2 Expert plus (Stuttgart, Germany). Energy will be expressed as a daily intake in kcal and MJ. Nutrient intakes will be expressed in (micro) grams/day, while carbohydrate, protein and fat intakes will also be expressed as a percentage of contribution to the daily energy intake. The intake of sea fish and the fatty acids, especially of DHA as well as the intake of probiotic products will be also precisely evaluated.
The nutrition of pregnant and breast-feeding mothers will be compared with the Central European reference intakes, D-A-CH (D-German, A-Austrian; CH-Swiss) Reference Values for Nutrient Intake which are official in Slovenia since 2004. The intake of fats, especially of DHA, will be compared with the recent consensus recommendations on fat intake during pregnancy and lactation. As the D-A-CH Reference Values do not define the maximum amount of daily sodium and sugar intake, we will compare the sodium and sugar intake with the joint WHO/FAO recommendations (population nutrient intake goal for sodium: \< 2 g/day and for free sugars: \< 10 % of daily energy intake). The proportion of n-3 LCP in plasma lipids of pregnant women will be compared to their diet. The blood obtained from the pregnant women will be analysed for the content of D vitamine and fatty acids composition of plasma lipids. The purpose of these additional test will be
* to establish whether the consumption of marine fish as well as supplements containing fish oil or unicellular organisms with n-3 LCP (EPA and DHA) (capsules, syrups), before and during pregnancy affects the increase of n-3 LCP in plasma lipids, and
* to assess the influence of dietary factors on bone mineral density in women, and the influence of the levels of vitamin D in the blood of mothers to the bone mineral density in neonates.
Among pregnant women included in the study of diet of pregnant and breast-feeding mothers in Slovenia, 40 mothers from each of regions will be randomly selected, after evaluating of inclusion and exclusion criteria, for the investigation of fatty-acid composition and microbial composition of human milk as well as analysis of faecal microbiota of infants.
Objectives:
* the assessment of fatty acids composition of human milk, with emphasis on LCPUFAs
* the investigation of the correlation between dietary DHA intake (4DP) and its content (wt. %) in mature human milk
* the assessment of microbial diversity of human colostrum and milk microbiota, with emphasis on bifidobacteria and lactic acid bacteria - potential probiotics
* the assessment of the prevalence of bacteriocin producing lactic acid bacteria in the natural microbiota of human colostrum and milk
* the assessment of microbial diversity of child's meconium and faeces
* comparison of milk and child's faecal microbiota
Statistic evaluation of final results will be performed by independent statistician from the Institute of Biostatistics and Medical informatics which has been already included in the preparation of the protocols of clinical studies (WP1).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women from Ljubljana region
Women at 3rd trimester of pregnancy living in the Ljubljana region.
No interventions assigned to this group
Pregnant women from Izola region
Women at 3rd trimester of pregnancy living in the Izola region.
No interventions assigned to this group
Pregnant women from Murska Sobota region
Women at 3rd trimester of pregnancy living in the Murska Sobota region.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* living in Slovenia
* intend to fully breast-feed their babies at least 6 weeks after delivery
* willing to write a 4-day weighted dietary protocol (7DP) twice: during pregnancy and again at 4 weeks post partum
Exclusion Criteria
* acute and chronic infections
* increased risk for premature delivery
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Centre Ljubljana
OTHER
University of Ljubljana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Irena Rogelj, Prof.
Role: PRINCIPAL_INVESTIGATOR
University of Ljubljana
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Centre Ljubljana, Division of Paediatrics, Department of Neonatology
Ljubljana, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Obermajer T, Grabnar I, Benedik E, Tusar T, Robic Pikel T, Fidler Mis N, Bogovic Matijasic B, Rogelj I. Microbes in Infant Gut Development: Placing Abundance Within Environmental, Clinical and Growth Parameters. Sci Rep. 2017 Sep 11;7(1):11230. doi: 10.1038/s41598-017-10244-x.
Obermajer T, Lipoglavsek L, Tompa G, Treven P, Lorbeg PM, Matijasic BB, Rogelj I. Correction: Colostrum of Healthy Slovenian Mothers: Microbiota Composition and Bacteriocin Gene Prevalence. PLoS One. 2015 Jun 29;10(6):e0132201. doi: 10.1371/journal.pone.0132201. eCollection 2015. No abstract available.
Soltirovska Salamon A, Benedik E, Bratanic B, Velkavrh M, Rogelj I, Fidler Mis N, Bogovic Matijasic B, Paro-Panjan D. Vitamin D Status and Its Determinants in Healthy Slovenian Pregnant Women. Ann Nutr Metab. 2015;67(2):96-103. doi: 10.1159/000439093. Epub 2015 Sep 5.
Benedik E, Korousic Seljak B, Hribar M, Rogelj I, Bratanic B, Orel R, Fidler Mis N. Comparison of a Web-Based Dietary Assessment Tool with Software for the Evaluation of Dietary Records. Zdr Varst. 2015 Mar 13;54(2):91-7. doi: 10.1515/sjph-2015-0014. eCollection 2015 Jun.
Benedik E, Korousic Seljak B, Simcic M, Rogelj I, Bratanic B, Ding EL, Orel R, Fidler Mis N. Comparison of paper- and web-based dietary records: a pilot study. Ann Nutr Metab. 2014;64(2):156-66. doi: 10.1159/000363336. Epub 2014 Aug 9.
Robic T, Benedik E, Fidler Mis N, Bratanic B, Rogelj I, Golja P. Challenges in determining body fat in pregnant women. Ann Nutr Metab. 2013;63(4):341-9. doi: 10.1159/000358339. Epub 2014 Mar 6.
Obermajer T, Pogacic T. Commentary: Relationship between Milk Microbiota, Bacterial Load, Macronutrients, and Human Cells during Lactation. Front Microbiol. 2016 Aug 17;7:1281. doi: 10.3389/fmicb.2016.01281. eCollection 2016. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
J4 3606 BF-UL My milk
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.